Buy or sell Synthace stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies
Synthace Stock
Synthace is a Life Sciences R&D cloud platform that enables experiments to be automated, with the resultant data seamlessly integrated.
About Synthace Stock
Synthace is a R&D cloud platform. Synthace aims to automate experimentation and insight sharing for scientists to share, view, and access progress with cures and therapeutics in one place.
Synthace was founded in 2011 and is headquartered in London, White City. Notable investors include Horizons Ventures, Sofinnova Partners, Amadeus Capital Partners, and Luminous Ventures.
Funding History
| August 2013 | $1.5M |
|---|---|
| January 2015 | $2.9M |
| September 2017 | $10.5M |
| June 2018 | $3.1M |
| December 2018 | $25.4M |
| November 2021 | $6.8M |
| November 2021 | $26.8M |
Management
CEO
Guy Levy-Yurista
Co-founder & Chief Scientific Officer
Markus Gershater
Chief Product Officer
Mathieu Ayel
Press
prnewswire - Dec, 7 2021
businesscloud - Nov, 17 2021
finsmes - Nov, 16 2021
ow - May, 20 2021
zpr - Mar, 9 2021
uktech - Nov, 5 2020
Other Companies
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
